首页> 中文期刊> 《中国现代医学杂志》 >MicroRNA-182在人肺腺癌中的表达及其临床意义

MicroRNA-182在人肺腺癌中的表达及其临床意义

             

摘要

目的 探讨microRNA-182(miRNA-182)在人肺腺癌组织中的表达,以及与患者临床特征及预后的相关性.方法 收集术后或穿刺活检病理证实的人肺腺癌新鲜组织98例,以及其癌旁正常肺组织和良性病变旁正常肺组织98例,实时荧光定量聚合酶链反应检测miRNA-182的相对表达量,分析其与临床特征及生存预后的关系,用ROC曲线评估miRNA-182对人肺腺癌的诊断能力.结果 miRNA-182在人肺腺癌组织相对表达量为(0.8001±0.2112),在正常肺组织相对表达量为(0.2721±0.1216),人肺腺癌组织中的表达高于正常肺组织(P<0.05);miRNA-182的表达水平与TNM分期、淋巴结转移、远处转移及肿瘤分化相关(P<0.05).ROC曲线分析发现,当界值设置为0.52时,miRNA-182在人肺腺癌中的表达特异性为95.918%,敏感性为91.837%,阳性预测值为95.745%.结论 miRNA-182在人肺腺癌组织中表达量高于正常肺组织,有可能成为人肺腺癌诊断、预后评估的重要指标.%Objective To study the level of microRNA-182 (miRNA-182) in human lung adenocarcinomas,and to evaluate its correlations with clinical features and prognosis of the patients with lung adenocarcinomas.Methods The fresh human lung adenocarcinoma tissues and their paired adjacent normal lung tissues of 98 cancer patients,and normal lung tissues of 98 cases with benign lesions were collected.All tissues of surgery or biopsy were confirmed by pathology,miRNA-182 was measured by qRT-PCR.The correlations of miRNA-182 with clinical features and prognosis of human lung adenocarcinomas were analyzed.The ROC curve was used to evaluate the ability of miRNA-182 in diagnosis of human lung adenocarcinomas.Results The level of miRNA-182 in the human lung adenocarcinomas (0.8001 ± 0.2112) was significantly higher than that in the normal lung tissues [(0.2721 ±-0.1216),P< 0.05].The level of miRNA-182 in human lung adenocarcinomas was correlated with TNM stage,lymphatic metastasis,distant metastasis and tumor differentiation (P < 0.05).After further analysis by ROC curve,the results showed that when the cut-off value was set to 0.52,the specificity,the sensitivity and the positive predictive value of miRNA-182 in human lung adenocarcinomas were 95.918%,91.837% and 95.745% respectively.Conclusions Level of miRNA-182 in human lung adenocarcinomas is significantly higher than that in normal lung tissues,it may be an important index for the diagnosis of human lung adenocarcinomas and prognosis evaluation.

著录项

  • 来源
    《中国现代医学杂志》 |2017年第26期|66-69|共4页
  • 作者单位

    第四军医大学唐都医院呼吸与危重症医学科,陕西西安710038;

    第四军医大学唐都医院呼吸与危重症医学科,陕西西安710038;

    第四军医大学唐都医院呼吸与危重症医学科,陕西西安710038;

    第四军医大学唐都医院呼吸与危重症医学科,陕西西安710038;

    第四军医大学唐都医院呼吸与危重症医学科,陕西西安710038;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肺肿瘤;
  • 关键词

    microRNA-182; 人肺腺癌; 诊断; 预后;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号